Inhibitor Therapeutics, Inc. (INTI)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$3.43M | -$3.66M | -$3.40M | -$657.9K | -$325.4K | -$1.06M | -$2.75M | -$4.56M | -$5.12M | -$7.02M |
| Net Income | -$3.30M | -$3.34M | -$3.03M | $12.11M | -$298.6K | -$1.06M | -$2.73M | -$4.55M | -$5.10M | -$7.00M |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.02 | $0.03 | $0.00 | — | — | — | — | — |
| Total Assets | $2.51M | $5.69M | $8.95M | $11.98M | $58.8K | $131.8K | $900.0K | $1.23M | $768.1K | $7.34M |
| Total Liabilities | $3.80M | $3.71M | $3.67M | $3.68M | $3.68M | $3.49M | $3.43M | $1.20M | $601.5K | $308.1K |
| Shareholders' Equity | -$1.29M | $1.99M | $5.28M | $8.30M | -$3.62M | -$3.36M | -$2.53M | $32.4K | $166.6K | $7.03M |
| Cash & Equivalents | $2.38M | $5.61M | $8.84M | $11.95M | $30.6K | $75.1K | $803.8K | $1.11M | $344.1K | $6.89M |
| Operating Cash Flow | -$3.23M | -$3.23M | -$2.70M | $11.74M | -$220.4K | -$825.4K | -$2.71M | -$3.71M | -$2.91M | — |
| Shares Outstanding | 172.57M | 172.32M | 172.02M | 171.79M | 376.86M | 373.64M | 370.45M | 370.08M | 369.60M | 353.45M |